References
Grof S, Goodman LE, Richards WA, Kurland AA (1973) LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsychiatry 8:129–144
Huxley A (1970) The Doors of Perception. Perenial Library, New York
Kast E (1966) LSD and the dying patient. Chic Med Sch Q 26:80–87
Kast EC, Collins VJ (1964) Lysergic acid diethylamide as an analgesic agent. Anesth Analg 43:285–291
Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131–181
Pahnke WN, Kurland AA, Goodman LE, Richards WA (1969) LSD-assisted psychotherapy with terminal cancer patients. Curr Psychiatr Ther 9:144–152
Pahnke WN, Kurland AA, Unger S, Savage C, Grof S (1970a) The experimental use of psychedelic (LSD) psychotherapy. JAMA 212:1856–1863
Pahnke WN, Kurland AA, Unger S, Savage C, Wolff MC, Goodman LE (1970b) Psychedelic therapy (utilizing LSD) with cancer patients. J Psychedelic Drugs 3:63–75
Schultes RE, Hofmann A (1979) Plants of the gods. Origins of hallucinogenic use. Alfred van der Marck Editions, New York
Strassman RJ (1996) Human psychopharmacology of N,N-dimethyltryptamine. Behav Brain Res 73:121–124
Strassman RJ, Qualls CR (1994) Dose–response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiatry 51:85–97
Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994) Dose–response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51:98–108
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nichols, D.E. Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.. Psychopharmacology 187, 284–286 (2006). https://doi.org/10.1007/s00213-006-0458-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-006-0458-4